Open AccessThe association of XPG and MMS19L polymorphisms response to chemotherapy in osteosarcoma
Author(s) -
YiLei Zhao,
Libin Yang,
Xiao-lin Geng,
Qinglan Zhou,
Hua Qin,
Lin Yang,
Yuzhen Dong,
Jin-Jie Zhong
Publication year - 2013
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.295.3747
Subject(s) - osteosarcoma , medicine , genotyping , chemotherapy , genotype , oncology , gastroenterology , cancer research , gene , genetics , biology
To assess the role of XPG, XPC, CCNH and MMS19L polymorphisms response to chemotherapy in osteosarcoma, and the clinical outcome of osteosarcoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom